Brussels: It emerged on Monday that Novavax (NVAX.O) would start providing its COVID-19 vaccines to the European Union (EU) in the first quarter of 2022. An EU source announced that the experts for the region’s drug regulator met on Monday to decide whether to authorize the shot. Nuvaxovid, if approved, would be the fifth coronavirus shot to be brought on to the EU market amidst the surge of Omicron.
